直观外科手术

最新新闻

• 评级变动
  Wells Fargo Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $487
  \u5e02\u573a\u8d44\u8baf · 2026/7/23
• 评级变动
  Raymond James Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Cuts Target Price to $483
  \u5e02\u573a\u8d44\u8baf · 2026/7/17
• 评级变动
  BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $470
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• 评级变动
  Leerink Partners Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Cuts Target Price to $454
  \u5e02\u573a\u8d44\u8baf · 2026/7/17
• 评级变动
  A Quick Look at Today's Ratings for Intuitive Surgical(ISRG.US), With a Forecast Between $450 to $685
  \u5e02\u573a\u8d44\u8baf · 2026/7/17
• 评级变动
  TD Cowen Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $485
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• Citi Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $500
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Oppenheimer Upgrades Intuitive Surgical(ISRG.US) to Buy Rating, Announces Target Price $500
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• RBC Capital Initiates Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $575
  \u5e02\u573a\u8d44\u8baf · 2026/10/3
• 评级变动
  HSBC Initiates Intuitive Surgical(ISRG.US) With Hold Rating, Announces Target Price $391
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  J.P. Morgan Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $450
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  BMO Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $518
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• Barclays Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Cuts Target Price to $485
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), Legend Biotech (LEGN) and Mineralys Therapeutics, Inc. (MLYS)
  TipRanks · 2026/8/12
• 评级变动
  BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $469
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• 评级变动
  Citi Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $500
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Bernstein Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $685
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• Piper Sandler Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $470
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  UBS Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Cuts Target Price to $500
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• Barclays Initiates Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $485
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• Intuitive Surgical(ISRG.US) Director Sells US$4 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  A Quick Look at Today's Ratings for Intuitive Surgical(ISRG.US), With a Forecast Between $500 to $670
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• Piper Sandler Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Maintains Target Price $470
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• 评级变动
  Mizuho Securities Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Cuts Target Price to $500
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Cuts Target Price to $600
  \u5e02\u573a\u8d44\u8baf · 2026/7/13

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。